Essex Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Essex Investment Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-8,938	Closed	-$1.54M	–	553
2018 Q3	$1.54M	Buy	+8,938	New	+$1.29M	0.18%	169
2016 Q4	–	Sell	-4,413	Closed	-$586K	–	390
2016 Q3	$586K	Buy	+4,413	New	+$422K	0.09%	233

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Essex Investment Management's GWPH Position: Q4 2018 in Review

Essex Investment Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2018, closing a stake of 8,938 shares — an estimated $1.54M sold.

Essex Investment Management first reported a position in GWPH in Q3 2016 and held it in 2 quarters. The position peaked at $1.54M in Q3 2018. 277 funds tracked by Wall St. Rank hold GWPH as of Q4 2018.

Essex Investment Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2018 after selling out during the quarter.
Essex Investment Management sold 8,938 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2018, an estimated $1.54M.
Essex Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2016 and held it in 2 quarters.
Essex Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.54M in Q3 2018.
277 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2018.

Based on Essex Investment Management's 13F filing for Q4 2018, filed 6 Feb 2019.